Logo
홈페이지
모델 살펴보기
장바구니
연락처
구독하기
연구 모델
HUGO Series 🌟
HUGO-GT™(희귀질환 연구)
HUGO-Ab™(항체 발굴)
MouseAtlas 모델 라이브러리
번개 세일
연구용 동물 모델
Cre 마우스
인간화 타겟 유전자 모델
대사 질환 모델
안과 질환 모델
신경질환 모델
자가면역 질환 모델
면역결핍 마우스 모델
인간화 면역계 마우스 모델
종양 및 면역 항암 모델
Covid-19 마우스 모델
세포주 모델
Knockout 세포주 제품 카탈로그
종양 세포주 제품 카탈로그
유도만능줄기세포(iPSC) 카탈로그
AAV 표준 제품 카탈로그
서비스
전임상 효능 평가
신경과학
알츠하이머병(AD)
파킨슨병(PD)
허팅턴병(HD)
안과학
녹내장
연령관련 황반변성(AMD)
종양학
PBMC 인간화 마우스 모델
면역항암 연구를 위한 인간 면역 시스템(HIS) 마우스
대사 및 심혈관 질환
자가면역 및 염증
유전자 변형 동물
Knockout 마우스
Transgenic 마우스
Knock-in 마우스
Knockout Rat
Knock-in(KI) Rat
Transgenic Rat
모델 제작 기술
Turboknockout™ 유전자 타겟팅
타겟 유전자 편집
일반 Transgenic
PiggyBac Transgenesis
BAC Transgenic
ES 세포 유전자 타겟팅
브리딩 및 지원 서비스
브리딩 서비스
동결 보존 및 복원
Phenotyping 서비스
BAC 변형 서비스
바이러스 패키징
AAV 패키징
렌티바이러스(Lentivirus) 패키징
아데노바이러스(Adenovirus ) 패키징
맞춤형 세포주 서비스
유도만능줄기세포(iPSCs)
Knockout(KO) 세포주
Knock-in(KI) 세포주
Point Mutation 세포주
과발현 세포주
모달리티
유전자 치료
AI 기반 AAV 발굴
Oligonucleotide 치료
세포 면역치료
Resource
프로모션
이벤트 및 웨비나
뉴스
블로그 및 인사이트
자료실
참고 데이터베이스
Peer-Reviewed 인용
희귀질환 데이터센터
AbSeek
Cell iGeneEditor™ System
OriCell 세포 배양
회사 소개
회사 소개
시설 개요
동물 건강 및 복지
건강 보고서
대리점
인재채용
문의하기
Login
필터
필터
KO/cKO Mouse Models
Flash Sales
HUGO-GT™ Platform
Full-Gene Humanized Models
Humanized Target Gene Models
Immune Target Humanized ModelsTumor Target Humanized ModelsMetabolic Target Humanized ModelsCytokine Humanized ModelsOther Target Humanized Models
Immune System Mouse Models
Immunodeficient Mouse ModelsHumanized Immune System Models
Genetic Tool Mouse Models
Cre Driver LinesReporter Mouse LinesOther Genetic Tool Lines
Specialized Disease Models
Ophthalmic Disease ModelsNeurological Disease ModelsMetabolic Disease ModelsOncology & Immuno-oncology ModelsAutoimmune Disease ModelsRare Disease ModelsInfectious Disease ModelsOther Disease Models
에 대한 검색 결과 8 건
필터
정렬 기준:
알파벳순 (A-Z)
베스트셀러
Cd7-Furin-GSG-T2A-Dre
제품 ID:
I001084
계통(Strain):
C57BL/6JCya
상태:
Live Mouse
설명:
The TGA stop codon of the mouse Cd7 gene is replaced with Furin-GSG-T2A-Dre. The Furin sequence helps to remove the 2A residues from the upstream protein, while the GSG linkers can provide the necessary space to ensure proper protein folding and self-cleavage of the 2A sequence.
The TGA stop codon of the mouse Cd7 gene is replaced with Furin-GSG-T2A-Dre. The Furin sequence helps to remove the 2A residues from the upstream protein, while the GSG linkers can provide the necessary space to ensure proper protein folding and self-cleavage of the 2A sequence.
Cd34-Dre
제품 ID:
I001068
계통(Strain):
C57BL/6JCya
상태:
Live Mouse
설명:
For the Kl model, the coding sequence of the exon 1 plus partial intron 1 was replaced with the Dre-rBG pA cassette. This model expresses Dre recombinase driven by the regulatory elements of the mouse Cd34 gene.
For the Kl model, the coding sequence of the exon 1 plus partial intron 1 was replaced with the Dre-rBG pA cassette. This model expresses Dre recombinase driven by the regulatory elements of the mouse Cd34 gene.
Cd68-loxP-Stop-loxP-DTR
제품 ID:
C001750
계통(Strain):
C57BL/6JCya
상태:
Live Mouse
설명:
The loxP-3*SV40 pA-loxP-IRES-DTR-rBG pA cassette was inserted downstream of the TGA stop codon. Upstream of the DTR (diphtheria toxin receptor) gene lies a loxP-Stop-loxP cassette that blocks DTR transcription and expression. Upon Cre recombination, Cre-mediated deletion of the loxP-flanked stop (LSL) element enables DTR expression in Cre-positive cells. Intravenous administration of diphtheria toxin (DT) then selectively ablates these cells.
The loxP-3*SV40 pA-loxP-IRES-DTR-rBG pA cassette was inserted downstream of the TGA stop codon. Upstream of the DTR (diphtheria toxin receptor) gene lies a loxP-Stop-loxP cassette that blocks DTR transcription and expression. Upon Cre recombination, Cre-mediated deletion of the loxP-flanked stop (LSL) element enables DTR expression in Cre-positive cells. Intravenous administration of diphtheria toxin (DT) then selectively ablates these cells.
H11-CAG-hCas
제품 ID:
C001827
계통(Strain):
C57BL/6JCya
상태:
Live Mouse
설명:
The CRISPR/Cas system has revolutionized genome editing by enabling precise and efficient genetic modifications in vivo [1-2]. This system consists of two principal components: the CRISPR-associated (Cas) endonucleases, which introduces site-specific double-strand breaks in DNA, and a guide RNA (gRNA), a short RNA sequence embedded within a scaffold that directs Cas to its genomic target via sequence complementarity [3]. H11-CAG-hCas mice carry a human codon-optimized Streptococcus pyogenes CRISPR-associated protein 9 (SpCas9) expression cassette, driven by the ubiquitous CAG promoter. This configuration ensures systemic expression of Cas protein across tissues. Notably, constitutive Cas expression in these mice does not elicit detectable toxicity, morphological abnormalities, tumorigenesis, or activation of DNA damage or apoptotic pathways. In the presence of sequence-specific single-guide RNAs (sgRNAs), this model enables efficient and simultaneous editing of single or multiple genes. H11-CAG-hCas mice are viable, fertile, and well-suited for a wide range of genome engineering applications.
The CRISPR/Cas system has revolutionized genome editing by enabling precise and efficient genetic modifications in vivo [1-2]. This system consists of two principal components: the CRISPR-associated (Cas) endonucleases, which introduces site-specific double-strand breaks in DNA, and a guide RNA (gRNA), a short RNA sequence embedded within a scaffold that directs Cas to its genomic target via sequence complementarity [3]. H11-CAG-hCas mice carry a human codon-optimized Streptococcus pyogenes CRISPR-associated protein 9 (SpCas9) expression cassette, driven by the ubiquitous CAG promoter. This configuration ensures systemic expression of Cas protein across tissues. Notably, constitutive Cas expression in these mice does not elicit detectable toxicity, morphological abnormalities, tumorigenesis, or activation of DNA damage or apoptotic pathways. In the presence of sequence-specific single-guide RNAs (sgRNAs), this model enables efficient and simultaneous editing of single or multiple genes. H11-CAG-hCas mice are viable, fertile, and well-suited for a wide range of genome engineering applications.
Itgax-Dre
제품 ID:
C001662
계통(Strain):
C57BL/6JCya
상태:
Live Mouse
설명:
The TGA stop codon was replaced with the "P2A-Dre" cassette. Dre recombinase is expressed under the regulatory control of Itgax gene elements.
The TGA stop codon was replaced with the "P2A-Dre" cassette. Dre recombinase is expressed under the regulatory control of Itgax gene elements.
Kit-LSL-T2A-DTR-P2A-Dre
제품 ID:
I001102
계통(Strain):
C57BL/6JCya
상태:
Live Mouse
설명:
The TGA stop codon of the mouse Kit gene is replaced with loxP-6*SV40 pA-loxP-T2A-DTR-P2A-Dre. When Kit-LSL-T2A-DTR-P2A-Dre mice are crossed with Cre mice, the 6*SV40 pA sequence in the offspring mice is deleted, and DTR (diphtheria toxin receptor) and Dre are expressed.
The TGA stop codon of the mouse Kit gene is replaced with loxP-6*SV40 pA-loxP-T2A-DTR-P2A-Dre. When Kit-LSL-T2A-DTR-P2A-Dre mice are crossed with Cre mice, the 6*SV40 pA sequence in the offspring mice is deleted, and DTR (diphtheria toxin receptor) and Dre are expressed.
RC-LR-DTR
제품 ID:
I001040
계통(Strain):
C57BL/6JCya
상태:
Live Mouse
설명:
The DTR system is a novel cell lineage ablation system based on the expression of the diphtheria toxin receptor (DTR) in transgenic mice and the administration of diphtheria toxin (DT). By knocking in the DTR gene at the target gene locus (usually a marker gene), selective ablation of cells expressing specific genes can be achieved [1]. When the target gene begins to be expressed in cells of mice that have been transgenically modified to express DTR, injection of DT can induce the death of these cells, resulting in apoptosis. The core of the DTR system is the toxic effect of DT, an exotoxin that, once it enters cells via its receptor, can catalyze the transfer of the ADP-ribosyl moiety from NAD+ to elongation factor 2 (EF-2) due to the ADP-ribosyltransferase activity present in its C-domain, resulting in EF-2 inactivation and inhibition of protein synthesis, ultimately leading to cell death [2]. Due to species differences in the sequence of the DTR gene, the diphtheria toxin receptor in mice cannot bind to DT [3]. This can be overcome by knocking in the primate DTR gene into the mouse genome, allowing specific cells to express DTR and enabling DT to enter specific cells upon administration, and resulting in cell-specific ablation. RC-LR-DTR mice are generated by combining the DTR system with the Cre-loxP and Dre-rox conditional recombinase systems. When these mice are crossed with Cre and Dre mice, DTR can be expressed specifically in tissues to induce tissue- and cell-specific ablation. Heterozygous RC-LR-DTR mice are viable and fertile, and homozygous RC-LR-DTR mice are also viable.
The DTR system is a novel cell lineage ablation system based on the expression of the diphtheria toxin receptor (DTR) in transgenic mice and the administration of diphtheria toxin (DT). By knocking in the DTR gene at the target gene locus (usually a marker gene), selective ablation of cells expressing specific genes can be achieved [1]. When the target gene begins to be expressed in cells of mice that have been transgenically modified to express DTR, injection of DT can induce the death of these cells, resulting in apoptosis. The core of the DTR system is the toxic effect of DT, an exotoxin that, once it enters cells via its receptor, can catalyze the transfer of the ADP-ribosyl moiety from NAD+ to elongation factor 2 (EF-2) due to the ADP-ribosyltransferase activity present in its C-domain, resulting in EF-2 inactivation and inhibition of protein synthesis, ultimately leading to cell death [2]. Due to species differences in the sequence of the DTR gene, the diphtheria toxin receptor in mice cannot bind to DT [3]. This can be overcome by knocking in the primate DTR gene into the mouse genome, allowing specific cells to express DTR and enabling DT to enter specific cells upon administration, and resulting in cell-specific ablation. RC-LR-DTR mice are generated by combining the DTR system with the Cre-loxP and Dre-rox conditional recombinase systems. When these mice are crossed with Cre and Dre mice, DTR can be expressed specifically in tissues to induce tissue- and cell-specific ablation. Heterozygous RC-LR-DTR mice are viable and fertile, and homozygous RC-LR-DTR mice are also viable.
Trhr-Flpo
제품 ID:
C001679
계통(Strain):
C57BL/6JCya
상태:
Live Mouse
설명:
The "P2A-Flpo" cassette was inserted upstream of TAA stop codon. Flpo recombinase is expressed under the regulatory control of Trhr gene elements.
The "P2A-Flpo" cassette was inserted upstream of TAA stop codon. Flpo recombinase is expressed under the regulatory control of Trhr gene elements.
Items: 1 to 8 of 8
1
더보기
전체 필터
Strain Type
Mouse
Rat
Modification Type
Knockout
Conditional Knockout
Knockin
Point Mutation
Transgenic
Conditional Knockin
Others
Status
Live Mice
R&D
Frozen Sperm
Validation Data
Verified
In Progress
초기화
확인
모델 라이브러리
모델 라이브러리
리소스
리소스
동물 품질
동물 품질
고객 지원
고객 지원
주소:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
전화:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
팩스:
408-969-0336
이메일:
[email protected]
연구 모델
HUGO-Ab™(항체 발굴)HUGO-GT™(희귀질환 연구)MouseAtlas 모델 라이브러리연구용 동물 모델
서비스
신경과학안과학종양학대사 및 심혈관 질환자가면역 및 염증
회사 소개
회사 소개시설 개요동물 건강 및 복지건강 보고서대리점인재채용문의하기
소셜 미디어
면책 조항: Cyagen의 제품 및 서비스 가격과 제공 여부는 지역에 따라 다를 수 있습니다. 명표시된 가격은 특정 국가에만 적용됩니다. 자세한 내용은 Cyagen으로 문의해 주시기 바랍니다.
Copyright © 2025 Cyagen. All rights reserved.
개인정보 처리방침
사이트 맵
Cyagen 최신 소식 받아보기
연구 모델, CRO 서비스, 과학 자료 및 특별 혜택에 대한 최신 소식을 연구 니즈에 맞춰 이메일로 받아보세요.
성명
이메일
조직
관심 분야
주요 연구 분야